State Street’s Belite Bio BLTE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.17M Buy
20,203
+105
+0.5% +$6.06K ﹤0.01% 3458
2025
Q1
$1.33M Buy
20,098
+81
+0.4% +$5.36K ﹤0.01% 3367
2024
Q4
$1.26M Sell
20,017
-69
-0.3% -$4.35K ﹤0.01% 3436
2024
Q3
$942K Buy
20,086
+4,415
+28% +$207K ﹤0.01% 3496
2024
Q2
$716K Sell
15,671
-999
-6% -$45.6K ﹤0.01% 3522
2024
Q1
$640K Sell
16,670
-887
-5% -$34K ﹤0.01% 3585
2023
Q4
$803K Buy
17,557
+592
+3% +$27.1K ﹤0.01% 3523
2023
Q3
$536K Buy
16,965
+3,580
+27% +$113K ﹤0.01% 3650
2023
Q2
$189K Buy
13,385
+921
+7% +$13K ﹤0.01% 4023
2023
Q1
$362K Buy
12,464
+696
+6% +$20.2K ﹤0.01% 3857
2022
Q4
$360K Buy
11,768
+1,160
+11% +$35.5K ﹤0.01% 3879
2022
Q3
$359K Buy
+10,608
New +$359K ﹤0.01% 3900